The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABEONA THERAPEUTICS INC | COM NEW | 00289Y206 | 334,784 | 108,696 | SH | SOLE | 108,696 | 0 | 0 | ||
ADMA BIOLOGICS INC | COM | 000899104 | 11,135,600 | 2,870,000 | SH | SOLE | 2,870,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 6,850,000 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
AKOYA BIOSCIENCES INC | COM | 00974H104 | 3,158,100 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 5,173,000 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 4,647,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,010,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | CALL | 04635X902 | 114,653 | 7,700 | SH | Call | SOLE | 7,700 | 0 | 0 | |
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 20,181,489 | 1,355,372 | SH | SOLE | 1,355,372 | 0 | 0 | ||
AULT DISRUPTIVE TECHS CORP | COM | 05150A104 | 1,537,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 9,305,040 | 1,132,000 | SH | SOLE | 1,132,000 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 2,776,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADS | 09071M205 | 1,831,145 | 3,103,635 | SH | SOLE | 3,103,635 | 0 | 0 | ||
BRUUSH ORAL CARE INC | *W EXP 08/03/202 | 11750K120 | 19,543 | 360,579 | SH | SOLE | 360,579 | 0 | 0 | ||
CARA THERAPEUTICS INC | COM | 140755109 | 2,104,610 | 195,960 | SH | SOLE | 195,960 | 0 | 0 | ||
CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 22,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CHAVANT CAPITAL ACQUISITN CO | *W EXP 99/99/999 | G2058L111 | 21,705 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 10,087,000 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
CINGULATE INC | *W EXP 12/10/202 | 17248W113 | 64,827 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | CLASS A ORD SHS | G2263T123 | 853,400 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 2,026 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 2,088,000 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
COLOMBIER ACQUISITION CORP | *W EXP 99/99/999 | 19533H116 | 1,433 | 16,666 | SH | SOLE | 16,666 | 0 | 0 | ||
COLOMBIER ACQUISITION CORP | CL A | 19533H108 | 497,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 2,704,500 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 6,426,750 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | ||
DIGITAL HEALTH ACQUISITION C | *W EXP 11/02/202 | 253893119 | 14,835 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
DIRECT DIGITAL HOLDINGS INC | *W EXP 02/15/202 | 25461T113 | 140,400 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
DOUBLEDOWN INTERACTIVE CO LT | ADS | 25862B109 | 514,402 | 60,876 | SH | SOLE | 60,876 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 3,862,600 | 620,000 | SH | SOLE | 620,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 7,413 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 683,270 | 227,000 | SH | SOLE | 227,000 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 3,974,880 | 91,000 | SH | SOLE | 91,000 | 0 | 0 | ||
GSR II METEORA ACQUISITN COR | UNIT 02/24/2027 | 36263W204 | 528,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 10/07/202 | 41150T124 | 38,935 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 17,400 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 99,800 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
HYRECAR INC | COM | 44916T107 | 715,763 | 1,688,120 | SH | SOLE | 1,688,120 | 0 | 0 | ||
INNOVATIVE EYEWEAR INC | *W EXP 08/16/202 | 45791D117 | 18,345 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 5,292,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 4,067,900 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
JEFFS BRANDS LTD | *W EXP 08/26/202 | M61472110 | 79,327 | 480,770 | SH | SOLE | 480,770 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 4,323,000 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
KORU MEDICAL SYSTEMS INC | COM | 759910102 | 3,052,350 | 855,000 | SH | SOLE | 855,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 349,937 | 28,198 | SH | SOLE | 28,198 | 0 | 0 | ||
LIGHTNING EMOTORS INC | COM | 53228T101 | 213,249 | 581,852 | SH | SOLE | 581,852 | 0 | 0 | ||
LIGHTNING EMOTORS INC | *W EXP 05/18/202 | 53228T119 | 25,304 | 652,173 | SH | SOLE | 652,173 | 0 | 0 | ||
MEDIWOUND LTD | SHS NEW | M68830112 | 368,088 | 27,286 | SH | SOLE | 27,286 | 0 | 0 | ||
MURPHY CANYON ACQUISITION CO | UNIT 01/25/2027 | 626642201 | 1,018,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MYRIAD GENETICS INC | COM | 62855J104 | 3,076,120 | 212,000 | SH | SOLE | 212,000 | 0 | 0 | ||
NEOGENOMICS INC | COM NEW | 64049M209 | 2,633,400 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 2,090,200 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 3,009,600 | 76,000 | SH | SOLE | 76,000 | 0 | 0 | ||
NEXALIN TECHNOLOGY INC | *W EXP 09/15/202 | 65345B110 | 21,000 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 33,750 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
NLS PHARMACEUTICS LTD | *W EXP 02/02/202 | H57830111 | 38,010 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 38,900 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
ONFOLIO HOLDINGS INC | *W EXP 01/02/202 | 68277K124 | 48,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
OPY ACQUISITION CORP I | *W EXP 09/22/202 | 671005114 | 3,225 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
OPY ACQUISITION CORP I | COM CL A | 671005106 | 501,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
OUTLOOK THERAPEUTICS INC | COM NEW | 69012T206 | 3,593,596 | 3,327,404 | SH | SOLE | 3,327,404 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 2,985,700 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
PEPGEN INC | COM | 713317105 | 534,800 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
PEPPERLIME HEALTH ACQUSTN CO | *W EXP 10/01/202 | G70021111 | 24,071 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | ||
PEPPERLIME HEALTH ACQUSTN CO | CLASS A ORD SHS | G70021103 | 7,504,350 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 1,933,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
POLISHED COM INC | COM | 28252C109 | 578,174 | 1,000,821 | SH | SOLE | 1,000,821 | 0 | 0 | ||
POLISHED COM INC | *W EXP 06/02/202 | 28252C117 | 488,306 | 6,103,824 | SH | SOLE | 6,103,824 | 0 | 0 | ||
PROSOMNUS INC | *W EXP 04/20/202 | 50535E116 | 11,790 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
QUANTERIX CORP | COM | 74766Q101 | 3,113,480 | 224,800 | SH | SOLE | 224,800 | 0 | 0 | ||
RELATIVITY ACQUISITION CORP | *W EXP 12/15/202 | 75944B114 | 3,010 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 4,352,000 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
RESMED INC | COM | 761152107 | 3,538,210 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 4,950,400 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
RXSIGHT INC | COM | 78349D107 | 640,925 | 50,586 | SH | SOLE | 50,586 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 1,907,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SELINA HOSPITALITY PLC | *W EXP 10/27/202 | G8059B119 | 8,115 | 101,439 | SH | SOLE | 101,439 | 0 | 0 | ||
SI-BONE INC | COM | 825704109 | 2,652,000 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
SOMALOGIC INC | CLASS A COM | 83444K105 | 778,100 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 7,023 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 1,131,101 | 315,070 | SH | SOLE | 315,070 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM NEW | 875372203 | 4,045,500 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 811,455 | 359,051 | SH | SOLE | 359,051 | 0 | 0 | ||
TC BIOPHARM HOLDINGS PLC | *W EXP 02/08/202 | 87807D111 | 1,684 | 18,823 | SH | SOLE | 18,823 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 712,600 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
TG THERAPEUTICS INC | CALL | 88322Q908 | 1,183,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
TG VENTURE ACQUISITION CORP | UNIT 08/15/2028 | 87251T208 | 2,038,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TILRAY BRANDS INC | CALL | 88688T900 | 20,444 | 7,600 | SH | Call | SOLE | 7,600 | 0 | 0 | |
TROIKA MEDIA GROUP INC | COM | 89689F305 | 310,026 | 2,672,640 | SH | SOLE | 2,672,640 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 2,061,850 | 43,000 | SH | SOLE | 43,000 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 5,617,950 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
WEARABLE DEVICES LTD | *W EXP 09/14/202 | M97838110 | 171,086 | 1,411,600 | SH | SOLE | 1,411,600 | 0 | 0 | ||
WESTERN ACQSTN VENTURES CORP | UNIT 09/01/2026 | 95758L206 | 1,100,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
XTANT MED HLDGS INC | COM NEW | 98420P308 | 4,122,552 | 6,246,291 | SH | SOLE | 6,246,291 | 0 | 0 |